ATE210974T1 - Verwendung von derivaten von 2,4-disubstituierten phenolen als 5-lipoxygenaseinhibitoren - Google Patents

Verwendung von derivaten von 2,4-disubstituierten phenolen als 5-lipoxygenaseinhibitoren

Info

Publication number
ATE210974T1
ATE210974T1 AT95908286T AT95908286T ATE210974T1 AT E210974 T1 ATE210974 T1 AT E210974T1 AT 95908286 T AT95908286 T AT 95908286T AT 95908286 T AT95908286 T AT 95908286T AT E210974 T1 ATE210974 T1 AT E210974T1
Authority
AT
Austria
Prior art keywords
alkyl
acyl
derivatives
phenyl
lipoxygenase inhibitors
Prior art date
Application number
AT95908286T
Other languages
English (en)
Inventor
De Falgas Joaquin Bonal
Belmonte Lorenzo Lopez
Navarro Luis Vila
Pujol Antonio Maria Molins
Novales Luis Lacoma
Original Assignee
Bobel246 S L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bobel246 S L filed Critical Bobel246 S L
Application granted granted Critical
Publication of ATE210974T1 publication Critical patent/ATE210974T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/24—Halogenated derivatives
    • C07C39/367—Halogenated derivatives polycyclic non-condensed, containing only six-membered aromatic rings as cyclic parts, e.g. halogenated poly-hydroxyphenylalkanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A61K31/055—Phenols the aromatic ring being substituted by halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A61K31/06—Phenols the aromatic ring being substituted by nitro groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/24—Halogenated derivatives
    • C07C39/26—Halogenated derivatives monocyclic monohydroxylic containing halogen bound to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/24—Halogenated derivatives
    • C07C39/26—Halogenated derivatives monocyclic monohydroxylic containing halogen bound to ring carbon atoms
    • C07C39/27—Halogenated derivatives monocyclic monohydroxylic containing halogen bound to ring carbon atoms all halogen atoms being bound to ring carbon atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
AT95908286T 1994-02-08 1995-02-06 Verwendung von derivaten von 2,4-disubstituierten phenolen als 5-lipoxygenaseinhibitoren ATE210974T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES09400217A ES2087019B1 (es) 1994-02-08 1994-02-08 Uso de derivados de fenoles 2,4-disubstituidos como inhibidores de la 5-lipoxigenasa.
PCT/ES1995/000017 WO1995021610A1 (es) 1994-02-08 1995-02-06 Uso de derivados de fenoles 2,4-disubstituidos como inhibidores de la 5-lipoxigenasa

Publications (1)

Publication Number Publication Date
ATE210974T1 true ATE210974T1 (de) 2002-01-15

Family

ID=8285128

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95908286T ATE210974T1 (de) 1994-02-08 1995-02-06 Verwendung von derivaten von 2,4-disubstituierten phenolen als 5-lipoxygenaseinhibitoren

Country Status (11)

Country Link
US (1) US5985937A (de)
EP (1) EP0707849B1 (de)
JP (1) JPH08511561A (de)
AT (1) ATE210974T1 (de)
AU (1) AU706305B2 (de)
BR (1) BR9505842A (de)
DE (1) DE69524709T2 (de)
ES (2) ES2087019B1 (de)
MX (1) MX9504248A (de)
NZ (1) NZ279509A (de)
WO (1) WO1995021610A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2134107C1 (ru) * 1998-10-12 1999-08-10 Тихоокеанский институт биоорганической химии Дальневосточного отделения РАН Препарат "гистохром" для лечения воспалительных заболеваний сетчатки и роговицы глаз
DE10040051A1 (de) * 2000-08-11 2002-02-21 Basf Ag Derivate des 4-(Trifluormethyl)-phenols sowie Derivate des 4-(Trifluormethylphenyl)-2-(tetrahydropyranyl)ethers und Verfahren zu ihre Herstellung
US6696466B1 (en) 2000-09-07 2004-02-24 Leslie Joe Dunaway Methods of treating select neuronal inflammatory disorders using hydroxyalkylquinolines
AU2002246135A1 (en) * 2002-03-14 2003-09-22 Bobel 246, S.L. Use of derivatives of 2,4-disubstituted phenols as inhibitors of the expression of l-selectins and of the isoform that is inducible from nitric oxide synthase
JP5537033B2 (ja) * 2005-12-19 2014-07-02 ザ ユニヴァーシティー オブ リヴァプール 無痛覚
WO2008141097A2 (en) * 2007-05-09 2008-11-20 Pharmacofore, Inc. Stereoisomers propofol therapeutic compounds
RU2470907C2 (ru) * 2007-05-09 2012-12-27 Сигничер Терапьютикс, Инк. Терапевтические соединения
EP2174654B1 (de) 2008-10-09 2012-08-22 Bobelium, S.L. Mikronisierte Zusammensetzung aus 2,4,6-Triiodophenol
CN107233337A (zh) 2009-04-29 2017-10-10 阿马里纳药物爱尔兰有限公司 含有epa和心血管剂的药物组合物以及使用其的方法
EP4132485B1 (de) 2020-04-07 2026-02-25 Wen Zhi LIN Phenol zur verwendung bei der behandlung von durch coronavirus induzierter dyspnoe
NL2025295B1 (en) * 2020-04-07 2021-10-25 Zhi Lin Wen Use of phenol in treatment of microbially induced dyspnoea

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4029816A (en) * 1975-11-25 1977-06-14 Merck & Co., Inc. Substituted 2-aminomethyl-6-iodophenols
AU576340B2 (en) * 1983-12-16 1988-08-25 Bislak S.A. Therapeutic applications of 2,4,6-triiodophenol
US4755524A (en) * 1986-01-31 1988-07-05 G. D. Searle & Co. Novel phenolic thioethers as inhibitors of 5-lipoxygenase
ES2056983T3 (es) * 1988-03-21 1994-10-16 Boehringer Ingelheim Pharma Compuestos para inhibir la biosintesis de metabolitos de acido araquidonico derivados de lipoxigenasa.

Also Published As

Publication number Publication date
US5985937A (en) 1999-11-16
ES2171532T3 (es) 2002-09-16
EP0707849A1 (de) 1996-04-24
ES2087019B1 (es) 1997-03-16
DE69524709T2 (de) 2002-08-08
NZ279509A (en) 1999-09-29
EP0707849B1 (de) 2001-12-19
ES2087019A1 (es) 1996-07-01
JPH08511561A (ja) 1996-12-03
BR9505842A (pt) 1996-02-13
AU706305B2 (en) 1999-06-10
WO1995021610A1 (es) 1995-08-17
AU1666295A (en) 1995-08-29
DE69524709D1 (de) 2002-01-31
MX9504248A (es) 1997-04-30

Similar Documents

Publication Publication Date Title
DE69924751D1 (de) Cephemverbindungen mit einem imidazo[4,5-b]pyridiniummethyl-rest, die ein breites antibakterielles wirkungsspektrum haben
DK0550113T3 (da) Triazolpyrimidinderivater med fungicid virkning
ATE153025T1 (de) Triazolopyrimidinderivate mit fungizider aktivität
ATE197045T1 (de) Isoxazolderivate als herbizide
HU9502512D0 (en) Anthranilic acid derivative
ATE137739T1 (de) N-acetonylbenzamide und ihre verwendung des fungizide
BG95818A (en) Herbicides
MY115311A (en) Optically active 2 - imidazoline - 5 - one derivatives as fungicides.
DE69524709D1 (de) Verwendung von derivaten von 2,4-disubstituierten phenolen als 5-lipoxygenaseinhibitoren
ATE205199T1 (de) Quinolin- oder quinazolinderivate, deren herstellung und verwendung
DE69208408D1 (de) Phenylthioharnstoffderivate und ihre pharmazeutische Verwendung
FI982476A0 (fi) Heteroatomeja sisältäviä trisyklisiä yhdisteitä
NO944371D0 (no) Kjemisk forbindelse med blodplateaggregeringsinhiberende virkning
ATE141272T1 (de) Beta-lactam-verbindungen und ihre herstellung
TW259785B (en) Chemical compounds
DK0594329T3 (da) Antimikrobielle midler, der omfatter polykvaternære ammoniumforbindelser
WO1991000729A3 (en) Bis-dioxopiperazines, and their use as protecting agents
DK0478173T3 (da) 4,5-polymethylen-4-isothiazolin-3-onderivater og anvendelse heraf som biocider
FI924657A0 (fi) Bis-(fenyl)etanderivat
BR9104876A (pt) Composicoes contra organismos aquaticos nocivos
ATE12103T1 (de) Thiolcarbamat-verbindungen und ihre verwendung als herbizide.
GR3006939T3 (de)
DE68907925D1 (de) Oxadiazolverbindungen, ihre herstellung und ihre verwendung als pestizide.
CA2160161A1 (en) Use of derivatives of 2,4-bisubstituted phenols as 5-lipoxigenase inhibitors
ATE32896T1 (de) Substituierte tropyl- und pseudotropylbenzoate und ihre verwendung bei der migraenebehandlung.